#Clinical

Em

DrEm_79

Self harm researchers and professionals:Why do you still write and talk about self harm as being “impulsive” or occurring due to “impulsiveness”?1. Do you think self harm is always “impulsive”?2.

Shazia Siddique MD MS

ShaziaMSiddique

Hot off the press: @US_FDA hearing on #COVID19 vaccine: Under EUA, pregnant & lactating women would be free to make their own decision on receiving the vaccine in conjunction with

Kenneth Rockwood

Krockdoc

1/4 Clinical Frailty Scale at Emergency Department triage https://pubmed.ncbi.nlm.nih.gov/33172880/ Good study, cautionary tale, and a useful spur to do more, especially with the #frailty stakes in COVID-19. Shrier et al/

John D. Cook

JohnDCook

In clinical studies of X vs Y, there's a lot going on besides the difference between X and Y. There are also numerous effects that are unaccounted for. The difference

Shane Crotty

profshanecrotty

1/ This is a truly excellent and important outcome. Greater than 90% efficacy at preventing disease, with 94 COVID-19 cases to evaluate, is an excellent outcome! It would be good

Jim Ritchie

ChorltonJim

Last thread of #CCIOHomeSchool before the weekend and lets try to tackle the existential question of what a CCIO is and does This is important not just for our own

Dinesh S. Thakur

d_s_thakur

I realize that memory is really fleeting, especially during these times where Science is sacrificed at the alter of ideology, but let me remind you what the Parliamentary Standing Committee

PoliMath

politicalmath

I'm fairly proud of my newsletter today.I'm utterly disgusted with vaccine politics in part because what is actually happening with the COVID vaccine is so INCREDIBLY FASCINATING!https://polimath.substack.com/p/operation-warp-speed-

Kimberly Blumenthal, MD, MSc

KimberlyBlumen1

1/Here is @CDCgov guidance for #allergy considerations about the @pfizer and @moderna_tx #COVID19vaccines : https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html#Contraindications#AIMedEd #medtwitter #allergyand

Madhu Menon

madmanweb

Who should take Covaxin? Nobody.It hasn't finished all clinical trials and there is no efficacy data for it. The company making it says this data will only be available in

Anant Bhan

AnantBhan

This is a letter which has been sent out by the ICMR DG yesterday. Now that multiple folks have confirmed genuineness, let me raise some issues with this letter on

Ziyad Al-Aly

zalaly

1/8 Here is a thread on our recent paper comparing the clinical manifestations and outcomes of people hospitalized with covid-19 or seasonal influenzahttps://www.bmj.com/content/371/bmj.m4677@bmj_latest @vahsrd @VAResearch @VASTLResearch @W

Alex Berenson

AlexBerenson

1/ Through Dec. 22, with fewer than 1 million doses of the #Covid vaccine given, @cdcgov's vaccine injury reporting system received 307 reports of ER visits and 17 "life threatening"

Chris Burton

chrisburton5

Some thoughts on increasing capacity for practice learning for #nursing and #AHP students #placements @councilofdeans @MRadford_HEECN 1/11 1.Reducing practice hours requirements through international benchmarking 2.Adopting a whole systems

Elad Sharon

EladSharonMD

In August, I enrolled in the @moderna_tx clinical trial for the #SARSCoV2 vaccine (mRNA-1273) that has now received an #EmergencyUseApproval by the @US_FDA. I saw this as my responsibility as

Natasha Rekhtman MD PhD

natasharekhtman

Excited to share FREE final PDF of our article with the amazing @mkbaine on SCLC subtypes https://authors.elsevier.com/a/1c0H65Xq2QKdvX @JTOonline. Thanks again to the entire team @charlesrudin @triparnasen @wvickylai & @MSKPathology! S

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.